HODGKIN DISEASE
Clinical trials for HODGKIN DISEASE explained in plain language.
Never miss a new study
Get alerted when new HODGKIN DISEASE trials appear
Sign up with your email to follow new studies for HODGKIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against Hard-to-Treat lymphomas
Disease control CompletedThis study tested a combination of two drugs, favezelimab and pembrolizumab, in 137 people with Hodgkin lymphoma and other B-cell blood cancers. The goal was to see if the combo is safe and can shrink tumors. Participants received the drugs alone or together, and researchers moni…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Double transplant from same donor could reduce lifelong Anti-Rejection drugs
Disease control CompletedThis study tested a combined bone marrow and kidney transplant from a partially matched related donor for 10 people with both a blood disorder and chronic kidney disease. The goal was to treat both conditions and possibly reduce the need for lifelong anti-rejection drugs after th…
Matched conditions: HODGKIN DISEASE
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New drug combo shows promise for Tough-to-Treat lymphoma in youth
Disease control CompletedThis early-stage study tested a combination of two immunotherapy drugs, relatlimab and nivolumab, in 5 children and young adults whose Hodgkin or non-Hodgkin lymphoma had returned or stopped responding to standard treatments. The main goals were to check safety, find the right do…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC
-
Fitness trackers tested for heart monitoring in cancer survivors
Knowledge-focused CompletedThis pilot study looked at whether a WHOOP wrist monitor can accurately measure resting heart rate and heart rate variability at home compared to standard in-office equipment. It involved 34 adult survivors of childhood Hodgkin lymphoma who had chest radiation. The goal was to se…
Matched conditions: HODGKIN DISEASE
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
New EHR tool sparks heart-health talks for cancer survivors
Knowledge-focused CompletedThis study tested a computer tool that helps doctors and cancer survivors discuss heart health during follow-up visits. 645 survivors of breast, prostate, colorectal, endometrial, or lymphoma cancers took part. The tool aimed to increase conversations about heart risks and referr…
Matched conditions: HODGKIN DISEASE
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC